Intimation/ Disclosure under Regulation 30 of SEBI(LODR) Regulation, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mr. Suraj Chagan Solanki (DIN: 10380845) has resigned from his position as Non-Executive Non-Independent Director of Welcure Drugs & Pharmaceuticals Ltd, effective close of business hours on 06th August 2025. The reason cited for his resignation is 'pre-occupation' (personal commitments). He has confirmed that there are no other material reasons behind his exit. The Board has acknowledged his contributions during his tenure. The intimation has been made to BSE under Regulation 30 of SEBI LODR Regulations, 2015, and is signed by Chintan Didawala Ganpat, the Managing Director & CFO.
This is a routine board-level change with a stated personal reason and no governance red flags. Shareholders are unlikely to see any material impact on operations or stock price, as the departing director held a non-executive, non-independent role.